Who You’ll Meet at the 7th Genome Editing Therapeutics Summit
With an 80% Director, VP & C-Suite level audience, the 7th Genome Editing Therapeutics Summit is where senior decisions are being made.
Explore the audience advancing genome editing therapeutics and CRISPR innovation this September in Boston.
Having trouble downloading the audience preview? Let us know and we’ll email it to you instead